<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: The development of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is characterized by multiple genetic alterations </plain></SENT>
<SENT sid="1" pm="."><plain>Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed </plain></SENT>
<SENT sid="2" pm="."><plain>It has recently been proven in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> systems that differentially expressed T-UCRs could alter the functional characteristics of malignant cells </plain></SENT>
<SENT sid="3" pm="."><plain>Genome-wide profiling revealed that T-UCRs have distinct signatures in human <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: In our study, we examined the expression levels of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.43, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.73, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.134, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.230, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.339, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.388 and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.399 in 54 samples of primary colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> and 15 samples of non-tumoral adjacent tissues by real-time PCR </plain></SENT>
<SENT sid="5" pm="."><plain>T-UCR expression levels were also correlated with commonly used clinicopathological features of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Expression levels of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.73 (p = 0.0139) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.388 (p = 0.0325) were significantly decreased in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissue, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.73 indicated a positive correlation with overall survival (p = 0.0315) </plain></SENT>
<SENT sid="7" pm="."><plain>The lower expression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.388 was associated with the distal location of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (p = 0.0183), but no correlation of any evaluated T-UCR with clinical stage, grade and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> diameter was observed </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Our preliminary results suggest that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.73 and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">uc</z:e>.388 could be potential diagnostic and prognostic biomarkers in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
</text></document>